Updates are available Correction dated 2025-05-15
Click to view Correction: https://doi.org/10.1186/s12933-025-02752-2
-
Authors
Quist, Sara W.
van Schoonhoven, Alexander V.
Bakker, Stephan J. L.
Pochopień, Michał
Postma, Maarten J.
van Loon, Jeanni M. T.
Paulissen, Jeroen H. J.
-
Funding
Funding for this research was provided by:
Bayer Pharmaceuticals, Netherlands
- License Information
-
More Information
Article History
Received: 18 August 2023
Accepted: 4 November 2023
First Online: 28 November 2023
Change Date: 15 May 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12933-025-02752-2
Declarations
:
: Not applicable.
: Not applicable.
: MJP reports grants and honoraria from various pharmaceutical companies, all unrelated to this specific work but some originating from companies developing, producing and marketing drugs in the field of CKD and T2D. SWQ, AVvS, SJLB, JHJP, JMTvL, and MP have no interests to declare.
